Enhancement of lymphokine-activated killer cell cytotoxicity implicated in the increased expression of surface adhesion molecules on tumor cells treated with anticancer agents

Cancer Investigation

Volumn 14, Issue 5, 1996, Pages 427-434

  Ishihata, Ryoichi ^a   Ejiri, Yutaka ^a   Okubo, Mitsuo ^a   Ohara, Morihiro ^a   Kasukawa, Reiji ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; CISPLATIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MESSENGER RNA; MITOMYCIN C;

ARTICLE; CANCER; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0029796935     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609018900     Document Type: Article

References (30)

1. Grimm EA, Mazumder A, Zhang HZ, et al: Lymphokine activated killer cell phenomenon: Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155:1823-1841, 1982.
2. Rosenberg SA, Lotze MT, Muul LM, et al: Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin 2 to patients with metastatic cancer. N Engl J Med 313:1485-1492, 1985.
3. Rosenberg SA, Lotze MT, Muul LM, et al: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316:889-897, 1987.
4. Berd D, Mastrangelo M, Engstrom P, et al: Augmentation of the human immune response by cyclophosphamide. Cancer Res 42: 4862-4867, 1982.
5. Ehrke MJ, Mihich E: Immunoregulation by cancer chemotherapeutic agents. In: The Reticuloendothelial System: A Comprehensive Treatise, Vol. 8, edited by JW Hadder, A Szentivanyi, New York, Plenum Press, 1985, pp 309-347.
6. Morikawa K, Hosokawa M, Hamada J, et al: Host-mediated therapeutic effects produced by appropriately limed administration of bleomycin on a rat fibrosarcoma. Cancer Res 45:1502-1506, 1985.
7. Stoychkov JM, Sclutz RM, Chirigos MA, et al: Effect of adriamycin and cyclophosphamide treatment on induction of macrophage-cytotoxic function in mice. Cancer Res 39:3014-3019, 1979.
8. Ogura T, Shindo H, Shinzato O, et al: In vitro tumor cell killing by peritoneal macrophages from mitomycin C treated rats. Cancer Immunol Immunother 13:112-117, 1982.
9. Kiyohara T, Taniguchi K, Kubota S, et al: Induction of lymphokine-activated killer-like cells by cancer chemotherapy. J Exp Med 168:2355-2360, 1988.
10. Liechtenstein AK, Peude D: Enhancement of natural killer cytotoxicity by cis-diamminedichloroplatinum (II). Cancer Res 40: 3099-3102, 1980.
11. Matheson DS, Green B, Hoar DJ: The influence of methotrexate and thymidine on the human natural killer cell function in vivo. J Immunol 131:1619-1621, 1983.
12. Hosokawa M, Sawamura Y, Morikage T, et al: Improved therapeutic effects of interleukin-2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide. Cancer Immunol Immunother 26:250-256, 1988.
13. Kawata A, Hosokawa M, Sawamura Y, et al: Modification of lymphokine activated killer cell accumulation into tumor sites by chemotherapy, local irradiation or splenectomy. Mol Biother 2: 221-227, 1990.
14. Yamaue H, Tanimura H, Noguchi K, et al: Cisplatin treatment renders tumor cells more susceptible to attack by lymphokine-activated killer cells. J Clin Lab Immunol 35:165-170, 1991.
15. Mizutani Y, Bonavida B, Nio Y, et al: Enhanced susceptibility of cis-diaminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells. Cancer 71:1313-1321, 1993.
16. Makgoba MW, Sanders ME, Ginter-Luce GE, et al: Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T-cell-mediated cytotoxicity. Eur J Immunol 18:637-640, 1988.
17. Show S, Luce GE, Quinones R, et al: Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones. Nature 323:262-264, 1986.
18. Altomonte M, Gloghini A, Bertola G, et al: Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res 53:3343-3348, 1993.
19. Jell JH, Stevenson AP, Warner NL, et al: Quantitation of cell surface antigen density by flow cytometry. Flow Cytom 4:215-221, 1980.
20. Chirgwin JM, Przybyla AE, MacDonald RJ, et al: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299, 1979.
21. Thomas PS: Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77:5201, 1980.
22. Saiki RK, Scharf S, Faloona F, et al: Enzymatic amplification of b-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354, 1985.
23. Iwasaki K: Studies on lymphokine-activated killer (LAK) activity and adoptive immunotherapy by LAK cells in patients with cancer in digestive organ. Fukushima Med J 40:405-417, 1990.
24. Kameyama K, Takezaki S, Kanzaki T, et al: HLA-DR and melanoma-associated antigen (p97) expression during the cell cycle in human melanoma cell lines, and the effects of recombinant gamma-interferon: Two-color flow cytometric analysis. J Invest Dermatol 87:313-318, 1986.
25. Zwelling LA: Mechanism of action of cis-diamminedichloroplatinum (II). Cancer Treat Rep 663:1439-1444, 1979.
26. Kontani H: Effect of mitomycin C on nucleic acid biosynthesis in Ehrlich ascites tumor cells. Biken J 7:9-20, 1964.
27. Ciaran P, Kelly J, O'keane C, et al: Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro. Am J Physiol 263:864-870, 1992.
28. Frederic M, Marc F: Regulation of HLA-DR gene by IFN-g transcriptional and post-transcriptional control. J Immunol 140:1660-1664, 1988.
29. Tomita Y, Watanabe H, Kobayashi H, et al: Expression of intercellular adhesion molecule-1 on transitional cell cancer. Am J Pathol 143:191-198, 1993.
30. Schwartz HS, Sodergren JE, Ambaye RY: Actinomycin D drug concentrations and actions in mouse tissues and tumors. Cancer Res 28:192-197, 1968.